Calian Sells U.S. IT Business to Trace3 for $31M
Event summary
- Calian Group Ltd. agreed to sell its U.S. commercial IT business to Trace3 for approximately $31M (USD) in upfront cash proceeds.
- The transaction includes the assumption of approximately $12M (USD) in net liabilities by Trace3.
- The deal is expected to close in Calian’s fourth fiscal quarter of 2026, subject to customary closing conditions.
- Calian generated a mid-teen IRR over five years of ownership of the business.
- Proceeds will be directed toward organic growth and M&A in Calian’s core verticals: defense, space, healthcare, and nuclear.
The big picture
Calian’s divestiture reflects a broader trend among mission-critical solutions providers to streamline portfolios and concentrate on high-growth, high-margin sectors. The $31M deal underscores the strategic value of enterprise technology solutions in the digital transformation landscape, particularly as Trace3 expands its footprint in the U.S. commercial IT market. The transaction also highlights Calian’s focus on optimizing capital allocation to fuel growth in its core verticals.
What we're watching
- Strategic Focus
- How Calian’s shift toward defense, space, and critical infrastructure will impact its competitive positioning.
- Capital Deployment
- Whether Calian can effectively redeploy the proceeds to drive organic growth and M&A in its core verticals.
- Integration Risk
- The pace at which Trace3 can integrate the acquired business and realize synergies.
Related topics